ContributorsPublishersAdvertisers

Kenneth Frazier

Fast Company

The key to leadership? Kenneth Frazier says it’s all about adopting your company’s values

Erectile dysfunction is not a condition that Merck & Co. wants to treat. Why? For Kenneth Frazier, executive chairman of the pharmaceutical conglomerate, ED doesn’t match the seriousness of diseases like cancer, HIV, or Ebola. When he was Merck’s CEO, Frazier chose to focus Merck’s research budget on less profitable, higher-impact solutions to the world’s deadliest viruses.
INDUSTRY
Picture for The key to leadership? Kenneth Frazier says it’s all about adopting your company’s values
RELATED CHANNELS

Merck CEO Kenneth Frazier Stepping Down

One prominent pharmaceutical company is about to swap out its CEO. Merck (NYSE:MRK) announced Thursday that its current leader, Kenneth Frazier, is retiring from his post, effective June 30. It did not provide any reason for his departure. He will be replaced by the company's present CFO, Robert Davis, who will also be given a seat on the board of directors.
BUSINESS
RELATED PEOPLE

UPDATE 5-Merck CEO Kenneth Frazier to retire at the end of June

NEW YORK, Feb 4 (Reuters) - Merck & Co Inc said on Thursday Kenneth Frazier, one of only a handful of Black executives leading major U.S. companies, will step down as chief executive officer at the end of June and be replaced by Chief Financial Officer Robert Davis. Frazier, 66,...
POTUS
RELATED PUBLISHERS